10^th International Virology Summit July 02-04, 2018 Vienna, Austria

Giulio Filippo Tarro has graduated from Medicine School, Naples University (1962). He was a Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. He was an Oncological Virology Professor, Naples University (1972-1985). Since 2007, he was the Chairman of Committee of Biotechnologies, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization Lifetime Achievement Award (2010). He is the President Foundation de Beaumont Bonelli for Cancer Research

Murine Virology,Antiviral Chemotherapy, Effects of inhibitors on viraI replication, Studies on the role of herpesviruses in cancer, Tumor immunology,Pathology of AIDS

Min-Hua Luo, M.D. & Ph.D., professor at Wuhan Institute of Virology, State Key Laboratory of Virology and CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT); affiliate assistant professor, University of Idaho. Dr. Luo received her BSc in Clinical Medicine in 1988; MSc in Microbiology in 1995 from Hunan Medical University; Ph.D. in Infectious Diseases in 1999, collaborate with Innsbruck University, Austria; Postdoct training in Shriver Center, Harvard Medical School in 2002; Research Scientist at Dept. MMBB, University of Idaho in 2004; Assistant professor at Dept. MMBB, University of Idaho in 2008; professor at Wuhan Institute of Virology, CAS in 2009; professor at CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) in 2014. Her research has focused on NEUROVIROLOGY and supported by funding resources of NSFC, NIH. "Hundred Talents" program from CAS, and "973" program from MOST.

Congenital HCMV Infection and Fetal Brain Development Disorders.

Dr. Bukrinsky obtained medical degree (M.D.) from the 2nd Moscow State Medical Institute in Moscow, Russia, and a doctorate (Ph.D.) in Molecular Biology from the Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. Currently Dr. Bukrinsky is Professor of Microbiology, Immunology and Tropical Medicine at the George Washington University School of Medicine and Health Sciences. He is a Fellow of the American Heart Association, the Editor-in-Chief of the Open AIDS Journal, and member of the Editorial Advisory Board of several biomedical journals. Dr. Bukrinsky’s research interests are in molecular mechanisms governing HIV replication and pathogenesis. His latest research focuses on changes in cholesterol metabolism induced by HIV and its protein Nef. Dr. Bukrinsky has published over 150 scientific papers, reviews and book chapters and is an inventor on 12 issued U.S patents.

HIV lifecycle, the mechanisms of HIV replication in host cells and the mechanisms of HIV pathogenesis and its effects on different tissues and organs, HIV-antigen-based diagnostic system

Zajac V has completed his PhD in 1982 from the Cancer Research Institute of Slovak Academy of Sciences in Bratislava (Slovakia), where he worked as the Head of Department of Cancer Genetics from 1996 to 2010. He joined the Medical Faculty of the Comenius University as an Associate Professor of Genetics in 2007. He has published 69 papers mostly in reputed journals and he was editor of the book “Bacteria, viruses and parasites in AIDS process” (InTech, 2011).

Vaccines, Immunology, Microbiology

Dr. Marco Ciotti has received his Medicine Degree in “La Sapienza” University of Rome in 1989; an Oncology degree at the University of Rome “Tor Vergata” in 1994, and a degree in Microbiology and Virology in 2001 in the same University. Since 2002, he works as Microbiologist at the University Hospital Tor Vergata, Rome, Italy. His main field of interests are HPV and cervical carcinogenesis, pathogenetic role of human polyomaviruses in immunocompromised patients, and diagnosis and molecular characterization of hepatitis viruses. He is serving as an editorial member of several reputed journals. He authored several research articles, one book, and chapters of books. He is a member of the Italian Society of Microbiology.

Human polyomaviruses,Hepatitis viruses

Prof Walsh’s group work on plant - virus interactions. He has published in excess of 270 research articles, 55 of which are in refereed scientific journals. He is particularly interested in natural plant resistance to viruses and has strong links with those who use the outcomes of his research and are involved in delivering them to the end users. The major thrust of this research is to identify, understand and exploit broad-spectrum, durable resistance to plant viruses. His group has had a number of major international (Spain, Germany, Holland, Sweden, Canada, China, Japan) and industry collaborations that have resulted in joint grants and joint publications. He is a past president of the International Working Group on Legume and Vegetable Viruses.

Plant virus interactions

Dr. Glorioso began his career as a professor in the Microbiology and Immunology and Laboratory Animal Medicine at the University of Michigan School of Medicine in 1976 and later in 1989, he moved to the University of Pittsburgh School of Medicine as the W.S McEllroy Professor and Chair of the Department of Microbiology and Molecular Genetics. He has established a 40-year history of research related to the basic biology and genetics of herpes simplex virus. His contributions to the field include defining antiviral immune responses to infection, the genetics of viral pathogenesis and latency, and mechanisms of viral infection. He has been a pioneer in the design and application of HSV gene vectors for the treatment of nervous system diseases such as peripheral neuropathies, chronic pain, and brain tumors. Dr. Glorioso’s most recent research has focused on (i) the design and application of HSV gene vectors for exploring the molecular events that occur in sensory afferents that are involved in the transition from acute to chronic pain, and he has been applied knowledge gained to the treatment of cancer-related pain in phase I clinical trials and (ii) the development of fully retargeted oncolytic HSV vectors for tumor-selective infection and microRNA controlled replication in human glioblastomas. This research has been applied to the treatment of syngeneic and xenograft models of human brain tumors. His research has launched two Biotech companies, Oncorus Inc. in Cambridge, MA and Coda Biotherapeutics Inc in San Francisco, CA. Oncorus utilizes oncolytic HSV vectors for the treatment of solid tumors by tumor lysis combined with immunomodulatory arming genes for induction of anti-tumor immunity. Coda Bio is a neuromodulation company that employs chemical genetics to silence painful conditions such as trigeminal and post-herpetic neuralgia and for treatment of neurogenic bladder, tremor and epilepsy.

HSV, viral infections

Dr. Ilya B. TSYRLOV graduated from Novosibirsk University Medical School (M.D. diploma with distinction). Received a Ph.D. in Biochemistry, and a D.Sci. (higher doctorate degree) in Biochemistry. Hold progressively responsible positions in academia, industry and govermental settings: Group Leader (1973-79), Head of Laboratory (1979-87), then Department of Xenobiochemistry (1987-92) at Russian National Academy of Science. In the United States: Senior Scientist at National Cancer Institute, NIH (1991-95); professor (1995-2010), then visiting associate professor (2010- ) at Mount Sinai School of Medicine, Department of Medicine. In 2005, founded and since then has served as Chief Scientific Officer at XENOTOX, Inc., an innovation science consulting non-profit company. Has forty years of experience and a world-class reputation in studies on molecular mechanisms of monooxygenases induction and drug metabolism; site-directed structure modification of analgesics, synthetic opioids, and antimalarials; research decoding mechanisms underlying human virus genome transcriptional activation by the most potent xenobiotic, dioxin. Established and developed Xenobiotical Virology, an interdisciplinary biomedical discipline dealing with mechanisms of potent xenobiotics’ effect on DRE-containing genes of human viruses, and transcription factors and cytokines linked to inflammation and malignancy pathways. Author of 4 monographs and 230+ peer reviewed publications.

Xenobiotical Virology

Doctor of Biological Sciences, Professor In 1969 he graduated from Yerevan State University with major in biochemistry. The most important outcomes of the scientific results: He has developed and proposed methods for diagnosis and differential diagnosis of diseases, for hemoblastosis prognosis, diagnosis and therapy methods. "Petamcin-A" is a medicine created by him which is introduced in practical medicine. Professor P. A. Ghazaryan has published 441 scientific papers and two textbooks (Moscow), two monographs (2012, Germany). He holds a number of patents. P.A. Ghazaryan headed 26 candidate and supervised 4 doctoral theses. Since 1975 he is a member of Specialized Council 042 on Biochemistry and Molecular Biology, and since 2005 he is deputy chief editor of the scientific journal "Blood". Since 2010 he is editor-in-response of "Pharma” 'scientific-practical journal. In 2007 he became a member of the American Association of Chemists. Then he was elected a full member (academician) of the Academies of Natural Sciences of RF (2008), of the Medical and Technical Sciences of RF (2009), the European Natural Sciences (Germany, 2010). Since 2012 he is the reviewer of the American Journal of Biochemistry, the Clinical Medicine and Diagnostics, and the American Journal of Medicine and Medical Sciences.

Molecular biology

Piotr Staszczuk was born on May 17, 1949 in Poland. He studied chemistry at the Maria Curie-Skłodowska University, graduated in 1972, received Ph.D in 1980 and Sc.D in 1987. He received the professor position at the Maria Curie-Skłodowska University in 1995 and the full professor title in 2001. In 1990-1992 he was the vice-Dean for education of the Faculty of Chemistry and in 1991-1992 he was the supervisor (protector) of the Department of Stereo- and Spectrochemistry. In 1989 he organized his research Thermal Analysis Group and he was the head of organized Department of Physicochemistry of Solid Surfaces in 1998-2006. He is the head of organized in 2010 of the Department (Cathedral) of Bionanomaterials, Institute of Biotechnology, the John Paul II Catholic University (KUL) of Lublin. In February 21, 2013 he was elected as director of Institute of Biotechnology, Faculty of Biotechnology and Natural Sciences of KUL.

Biotechnology